Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2162-2169

  Davignon, Jean Luc ^a   Castanié, Patrick ^a   Yorke, Justine Allan ^a   Gautier, Nicolas ^a   Clèment, Danièle ^a   Davrinche, Christian ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE;

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION; VIROGENESIS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029872228     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2162-2169.1996     Document Type: Article

References (46)

1. Alford, C. A., and W. J. Britt. 1990. Cytomegalovirus, p. 1981-2010. In B. N. Fields, D M. Knipe, et al. (ed.). Virology, 2nd ed. Raven Press Ltd., New York.
2. Alp, N. J., T. D. Allpprt, J. van Zanten, B. Rodgers, J. G. P. Sissons, and L. K. Borysiewicz. 1991 Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J. Virol. 65:4812-4820
3. Barnaba, V., A. Franco, M. Paroli, R. Benvenuto, G. De Petrillo, V. L. Burgio, I. Santilio, C. Balsano, M. S. Bonavita, G. Cappelli, V. Colizzi, G. Cutrona, and M. Ferrarini. 1994. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helpci type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 152:3074-3087
4. Beersma, M. F. C., M. J. Bijlmakers, and H. I. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I chains. J. Immunol. 151:4455-4464.
5. Biron, C. 1994. Cytokines in the generation of immune responses to. and resolution of, virus infection Curr. Opin. Immunol. 6:530-538.
6. Davignon, J.-L., D. Clement, J. Alriquet, S. Michelson, and C. Davrinche. 1995. Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability. Scand. J. Immunol. 41:247-255.
7. Davignon, J.-L., S. Michelson, and C. Davrinche. 1993. Presentation of human cytomegalovirus immediate-early (IE1) protein by astrocytoma cells to a CD4+ T cell clone, p. 139-144. In S. Michelson and S. A. Plotkin (ed.), Multidisciplinary approach to understanding cytomegalovirus disease, proceedings of the 4th international CMV workshop. Excerpta Medica. Amsterdam.
8. + T-cell clones. Biochem. Biophys. Res. Commun. 195:469-477.
9. Doherty, P. C., W. Allan, and M. Eichelberger. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
10. Duclos, H., E. Elfassi, S. Miehelson, F. Arenzana-Seisdedos, A. Munier, and J.-L. Virelizier. 1989. Cytomegalovirus infection and trans-activation of HIV-1 and HIV-2 LTRs in human astrocytoma cells. AIDS Res. Human Retroviruses 5:217-224.
11. Feduchi, E., M. A. Alonso, and L. Carrasco. 1989. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1354-1359.
12. Ferrari, C., M. U. Mondelli, A. Penna, F. Fiaccadori, and F. V. Chisari. 1987. Functional characterization of cloned intrahepatic. hepatitis B virus nucleoprotein-specific helper T cell lines J. Immunol. 139:539-544.
13. 12a. Gautier, N., et al. Submitted for publication.
14. Geist, L. J., M. M. Monick, M. F. Stinski, and G. W. Hunninghake. 1994. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J. Clin. Invest. 93:474-4-78.
15. Gilbert, M., S. Riddell, C.-R. Li, and P. Greenberg. 1993 Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus J Virol. 67:3461-3469.
16. Hengel, H., P. Lucin, S. Jonjic, T. Ruppert, and U. H. Kaszinowski. 1994. Restoration of cytomegalovirus antigen presentation by gamma interteron combats viral escape. J. Virol. 68:289-297.
17. Israël, N., U. Hazan. J. Alcami, A. Munnier, F. Arenzana-Seisdedos. F. Bachelerie, A. Israel, and J.-L. Virelizier. 1989. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:3956-3960.
18. + T lymphocytes. J. Virol. 64:5457-5464.
19. Kaufman, S. H. 1993 Immunity to intracellular bacteria. Annu Rev. Immunol. 11:129-163
20. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl. Acad. Sci USA 91:11879-11883
21. Lewis, D. B., K. S. Prickett, A. Larsen, K. Grabstein, M. Weaver, and C. B. Wilson. 1998. Restricted production of interleukin 4 by activated human T cells. Proc Natl Acad. Sci USA 85:9743-9747.
22. Lindsley, M. D., D. J. Torpey III, and C. R. Rinaldo, Jr. 1986. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive cells J. Immunol. 136:3045-3051.
23. Liu, Y.-N. C., J. Eckhardt, B. Kari, and R. C. Gehrz. 1988. General characterization of human cytomegalovirus-specific proliferative CD4+ T cell clones Int. J. Cell Cloning 6:352-364.
24. Lucin, P., S. Jonjic, M. Messerle, B. Bolic, H. Hengel, and U. H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J. Gen Virol. 75:101-110.
25. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U. H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands J. Virol. 66:1977-1984.
26. Marshall, G. S., G. P. Rabalais, G. G. Stout, and S. L. Waldeyer. 1992. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J. Infect Dis. 165:381-384
27. Mazeron, M. C., G. Jahn, and B. Platcher. 1992. E-13 monoclonal antibody to human cytomegalovirus recognizes several immediate early proteins. J. Gen. Virol. 73:2699-2701.
28. McLaughlin-Taylor, E., H. Pande, S. J. Forman, B. Tamanachi, C.-R. Li, J. A. Zaia, P. D. Greenberg, and S. R. Riddell. 1994. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med. Virol. 43:103-110.
29. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Möller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature (London) 323:816-819.
30. + T cell clones in vitro. Vaccine, in press.
31. Prigione, I., P. Facchetti, P. Tasso, and V. Pistoia. 1995. Toxoplasma gondiis-pecific CD4+ T cell clones from healthy. latently infected humans display Th0 profile of cytokine secretion. Eur. J Immunol. 25:1298-1305.
32. Quinnan, G. V., N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. Moreschi, G. Santos, R. Saral, and W. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection. HLA-restricted T lymphocyte and non-T lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow transplant recipients. N. Engl. J Med. 307:7-13.
33. Rasmussen, L., C. Matkin, R. Spaete, C. Pachl, and T. C. Merigan. 1991. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J. Infect. Dis. 164:835-842.
34. Reed, S. G., and P. Scott. 1993. T-cell and cytokine responses in leishmaniosis. Curr. Opin. Immunol. 5:524-531.
35. Romagnani, S. 1994. Lymphokine production in disease states. Annu. Rev. Immunol. 12:227-257.
36. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
37. Smith, P. D., S. S. Saini, M. Raffeld, J. F. Manischewitz, and S. M. Whal. 1992. Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J. Clin. Invest. 90:1642-1648.
38. Stein, J., H.-D. Volk, C. Liebenthal, D. H. Krüger, and S. Prösch. 1993. Tumor necrosis a stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J. Gen. Virol 74:2333-2338
39. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol 68:1597-1604.
40. Torigoe, S., D. E. Campbell, F. Torigoe, S. Michelson, and S. E. Starr. 1993. Cytofluorographic analysis of effects of interferons on expression of human cytomegalovirus proteins J. Virol Methods 45:219-228.
41. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors Annu. Rev. Immunol. 10:411-452.
42. Waldman, W. J., D. A. Knight, P. W. Adams, C. G. Orosz, and D. D. Sedmak. 1993. In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells. Transplantation 56:1504-1512
43. Warren, A. P., D. H. Ducroq, P. J. Lehner, and L. K. Borysiewicz. 1994. Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes. J. Virol. 68:2822-2829.
44. Wong, G. H. W., and D. V. Goeddel. 1986. Tumour necrosis factors a and β inhibit virus replication and synergize with interferons. Nature (London) 323:819-822.
45. Yasukawa, M., A. Inatsuki, T. Horinchi, and Y. Kobayashi. 1991. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells. J Immunol. 146:1341-1347.
46. Zhang, Y., M. Cosyns, M. J. Levin, and A. R. Hayward. 1994. Cytokine production in varicella-zoster virus-stimulated limiting dilution lymphocyte cultures. Clin. Exp. Immunol. 98:128-133.